THE Philippine Food and Drug Administration has approved a certificate of product registration (CPR) for a local drug company to manufacture human-grade ivermectin as an "anti-nematode drug".
FDA Director-General Rolando Enrique Domingo confirmed to The Manila Times that Lloyd Laboratories has been given CPR.
Already have an active account? Log in here.
Continue reading with one of these options:
Continue reading with one of these options:
Premium + Digital Edition
Ad-free access
P 80 per month
(billed annually at P 960)
- Unlimited ad-free access to website articles
- Limited offer: Subscribe today and get digital edition access for free (accessible with up to 3 devices)
TRY FREE FOR 14 DAYS
See details
See details
If you have an active account, log in
here
.